DNMT3A and acute myeloid leukemia: Of the three genes in the glasdegib + LDAC arm, OS correlated only with mutations in DNMT3A (HR 4.35; 95% CI 1.40–13.53; p = 0.0056), where patients with secondary AML and mutated DNMT3A had a shorter OS than patients with wild-type DNMT3A; the mutational status of DNMT3A did not influence OS in patients with de novo AML.